Shaw; Kenneth J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shaw; Kenneth J..The latest application filed is for "imidazolidinedione analogs useful as anticoagulants and antithrombotics".

Company Profile

0.17.6

Shaw; Kenneth J. - Essex Junction VT
Shaw; Kenneth J. - Brookside NJ
Shaw; Kenneth J. - San Rafael CA
Shaw; Kenneth J. - Califon NJ
Shaw; Kenneth J. - Orangeburg NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nodal charge compensation for SST driver having data mux in output stage Grant 7,511,530 - Cox , et al. March 31, 2	2009-03-31
Piperazine derivatives and their use as anti-inflammatory agents Grant 7,268,140 - Bauman , et al. September 11, 2	2007-09-11
Imidazolidinedione analogs useful as anticoagulants and antithrombotics Grant 7,199,146 - Arnaiz , et al. April 3, 2	2007-04-03
Imidazolidinedione analogs useful as anticoagulants and antithrombotics App 20060142363 - Arnaiz; Damian O. ; et al.	2006-06-29
Piperazine derivatives and their use as anti-inflammatory agents App 20060135487 - Bauman; John G. ; et al.	2006-06-22
Imidazolidinedione analogs useful as anticoagulants and antithrombotics Grant 7,053,112 - Arnaiz , et al. May 30, 2	2006-05-30
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,977,258 - Bauman , et al. December 20, 2	2005-12-20
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,972,290 - Bauman , et al. December 6, 2	2005-12-06
Imidazolidinedione analogs useful as anticoagulants and antihrombotics App 20040122073 - Arnaiz, Damian O. ; et al.	2004-06-24
Piperazine derivatives and their use as anti-inflammatory agents App 20030158205 - Bauman, John G. ; et al.	2003-08-21
Piperazine derivatives and their use as anti-inflammatory agents App 20030139425 - Bauman, John G. ; et al.	2003-07-24
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,555,537 - Bauman , et al. April 29, 2	2003-04-29
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,541,476 - Bauman , et al. April 1, 2	2003-04-01
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,534,509 - Bauman , et al. March 18, 2	2003-03-18
Ortho-anthranilamide derivatives as anti-coagulants Grant 6,498,185 - Arnaiz , et al. December 24, 2	2002-12-24
Piperazine derivatives and their use as anti-inflammatory agents App 20020177598 - Bauman, John G. ; et al.	2002-11-28
Ortho-anthranilamide derivatives as anti-coagulants Grant 6,380,221 - Arnaiz , et al. April 30, 2	2002-04-30
Ortho-anthranilamide derivatives as anti-coagulants Grant 6,140,351 - Arnaiz , et al. October 31, 2	2000-10-31
Naphthyl-substituted benzimidazole derivatives as anti-coagulants Grant 5,849,759 - Arnaiz , et al. December 15, 1	1998-12-15
(Z,Z), (Z,E) and (E,Z) isomers of substituted bis(phenylmethylene)cycloketones Grant 5,633,381 - Dallas , et al. May 27, 1	1997-05-27
Inhibitors of the conversion of big endothelin to endothelin Grant 5,504,070 - Bihovsky , et al. April 2, 1	1996-04-02
Low power, high performance PLA Grant 5,311,079 - Ditlow , et al. May 10, 1	1994-05-10
Unsymmetrical 1,4-bis(aminoalkylamino)-anthracene-9, 10-diones and derivatives Grant 4,894,451 - Krapcho , et al. January 16, 1	1990-01-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.